Tue, March 24, 2026 at 2:52 PM UTC Pfizer (NYSE:PFE) has quietly built momentum in 2026, with shares up 6.61% year-to-date and 2.70% over the past year. The stock is currently trading near $26.84 but ...
Pfizer (PFE) is trading at $26.59 with shares up 9.31% year-to-date, while Guggenheim raised its price target to $36 with a Buy rating versus Wall Street’s cautious $28.14 consensus. Pfizer’s oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results